-4.50 (-0.27%) Sun Pharmaceutical Industries has informed that it enclosed Press Release relating to ‘Sun Pharma Announces US FDA Filing Acceptance of New Drug Application (NDA) For Deuruxolitinib’.
The above information is a part of company’s filings submitted to BSE.